Nitric Oxide-Donating Derivatives of Chrysin Stimulate Angiogenesis and Upregulating VEGF Production

Abstract:

Angiogenesis, the development of new capillaries from pre-existing vessels, requires the coordinate activation of endothelial cells, which migrate and proliferate to form functional vessels. Endothelial dysfunction and decreased nitric oxide bioavailability may underscore the impairment of angiogenesis. As such, the delivery of exogenous NO is an attractive therapeutic option that has been used to therapeutic angiogenesis. In this paper, a novel group of hybrid nitric oxide-releasing chrysin derivatives was synthesized. The results indicated that all these chrysin derivatives exhibited promotion of endothelial migration and tubulogenesis in vitro as well as stimulation angiogenesis in vivo.Furthermore, all compounds released NO upon incubation with phosphate buffer at pH 7.4 and enhanced VEGF secretion and VEGF mRNA expression of endothelial cells. These hybrid ester NO donor prodrugs offer a potential drug design concept for the development of therapeutic or preventive agents for angiogenesis deficiency due to ischemic diseases.

• Periodical: Advanced Materials Research (Volume 340)
• Pages: 363-368
• DOI: https://doi.org/10.4028/www.scientific.net/AMR.340.363
• Online since: September 2011
• Authors: Xiao Qing Zou, Yong Lan Ding, Sheng Ming Peng, Chang Ping Hu, Han Wu Deng, Yuan Jian Li
• Keywords: Angiogenesis, Chrysin Derivatives, Hybrid, Nitric Oxide Donor

References

[1] K. Lirdprapamongkol, et al., Juice of eclipta prostrata inhibits cell migration in vitro and exhibits anti-angiogenic activity in vivo, In Vivo, vol. 22, pp.363-8, May-Jun (2008).

[2] R. Domenico, Pharmacology of nitric oxide: molecular mechanisms and therapeutic strategies, Curr Pharm Des, vol. 10, pp.1667-76, (2004).

[3] C. G. da Silva, et al., Mechanism of purinergic activation of endothelial nitric oxide synthase in endothelial cells, Circulation, vol. 119, pp.871-9, Feb 17 (2009).

DOI: 10.1161/circulationaha.108.764571

[4] G. S. Sim, et al., Structure activity relationship of antioxidative property of flavonoids and inhibitory effect on matrix metalloproteinase activity in UVA-irradiated human dermal fibroblast, Arch Pharm Res, vol. 30, pp.290-8, Mar (2007).

DOI: 10.1007/bf02977608

[5] O. Kagami, et al., Protein engineering on biphenyl dioxygenase for conferring activity to convert 7-hydroxyflavone and 5, 7-dihydroxyflavone (chrysin), J Biosci Bioeng, vol. 106, pp.121-7, Aug (2008).

DOI: 10.1263/jbb.106.121

[6] T. Zhang, et al., Chrysin and its phosphate ester inhibit cell proliferation and induce apoptosis in Hela cells, Bioorg Med Chem, vol. 12, pp.6097-105, Dec 1 (2004).

DOI: 10.1016/j.bmc.2004.09.013

[7] E. Ognibene, et al., Behavioral effects of 6-bromoflavanone and 5-methoxy-6, 8-dibromoflavanone as anxiolytic compounds, Prog Neuropsychopharmacol Biol Psychiatry, vol. 32, pp.128-34, Jan 1 (2008).

DOI: 10.1016/j.pnpbp.2007.07.023

[8] E. K. Shin, et al., Chrysin, a natural flavone, improves murine inflammatory bowel diseases, Biochem Biophys Res Commun, vol. 381, pp.502-7, Apr 17 (2009).

DOI: 10.1016/j.bbrc.2009.02.071

[9] R. Lopez-Posadas, et al., Effect of flavonoids on rat splenocytes, a structure-activity relationship study, Biochem Pharmacol, vol. 76, pp.495-506, Aug 15 (2008).

[10] S. Matsumoto, et al., Solution structure of the variable-type domain of the receptor for advanced glycation end products: new insight into AGE-RAGE interaction, Biochemistry, vol. 47, pp.12299-311, Nov 25 (2008).

DOI: 10.1021/bi800910v

[11] T. Lapidot, et al., Antioxidant and prooxidant effects of phenolics on pancreatic beta-cells in vitro, J Agric Food Chem, vol. 50, pp.7220-5, Dec 4 (2002).

DOI: 10.1021/jf020615a

[12] S. M. Peng, et al., Synthesis and promotion angiogenesis effect of chrysin derivatives coupled to NO donors, Bioorg Med Chem Lett, Jan 10 (2009).

[13] D. Liu, et al., Dehydroepiandrosterone stimulates endothelial proliferation and angiogenesis through extracellular signal-regulated kinase 1/2-mediated mechanisms, Endocrinology, vol. 149, pp.889-98, Mar (2008).

DOI: 10.1210/en.2007-1125

[14] P. Dufourcq, et al., FrzA, a secreted frizzled related protein, induced angiogenic response, Circulation, vol. 106, pp.3097-103, Dec 10 (2002).

DOI: 10.1161/01.cir.0000039342.85015.5c

[15] X. Q. Zou, et al., Synthesis, characterization and vasculoprotective effects of nitric oxide-donating derivatives of chrysin, Bioorg Med Chem, vol. 18, pp.3020-5, May 1.

[16] J. Xiao, et al., Involvement of dimethylarginine dimethylaminohydrolase-2 in visfatin-enhanced angiogenic function of endothelial cells, Diabetes Metab Res Rev, vol. 25, pp.242-9, Mar (2009).

DOI: 10.1002/dmrr.939

[17] O. Tarasenko, et al., Killing of Bacillus spores is mediated by nitric oxide and nitric oxide synthase during glycoconjugate-enhanced phagocytosis, Glycoconj J, vol. 27, pp.13-25, Jan.

DOI: 10.1007/s10719-009-9248-7

[18] D. W. Leung, et al., Vascular endothelial growth factor is a secreted angiogenic mitogen, Science, vol. 246, pp.1306-9, Dec 8 (1989).

DOI: 10.1126/science.2479986

[19] K. A. Thomas, Vascular endothelial growth factor, a potent and selective angiogenic agent, J Biol Chem, vol. 271, pp.603-6, Jan 12 (1996).

DOI: 10.1074/jbc.271.2.603